SCHEMBL1624932

SCHEMBL1624932

Cc1ccc2c(N3CCCC(CN(C(=O)O)C(C)(C)C)C3)nc(-c3ccccc3O)nc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 5/20 0.50
SMAD3 P84022 1/20 0.46
MAPT P10636 4/20 0.43
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 4/20 0.40
TSHR P16473 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
GBA1 P04062 1/20 0.38
KDM4E B2RXH2 3/20 0.36
HPGD P15428 2/20 0.36
HSD17B10 Q99714 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
LMNA P02545 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
USP2 O75604 1/20 0.36
MAPK1 P28482 1/20 0.36
HIF1A Q16665 3/20 0.35
TLR7 Q9NYK1 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1624537 1.00 CHEK2 (0.50) CHEK2SMAD3MAPTKMT2AMEN1
SCHEMBL1621584 0.88 CHEK2 (0.49) CHEK2SMAD3MAPTKMT2AMEN1
SCHEMBL1624504 0.88 CHEK2 (0.49) CHEK2SMAD3MAPTKMT2AMEN1
SCHEMBL1623155 0.87 CHEK2 (0.48) CHEK2SMAD3MAPTKMT2AMEN1
SCHEMBL1624731 0.87 CHEK2 (0.48) CHEK2SMAD3MAPTKMT2AMEN1
SCHEMBL1622730 0.87 CHEK2 (0.48) CHEK2SMAD3MAPTKMT2AMEN1
SCHEMBL1624109 0.87 CHEK2 (0.48) CHEK2SMAD3MAPTKMT2AMEN1
SCHEMBL1624542 0.87 CHEK2 (0.47) CHEK2SMAD3MAPTKMT2AMEN1
SCHEMBL1622769 0.86 CHEK2 (0.47) CHEK2SMAD3MAPTKMT2AMEN1
SCHEMBL1624368 0.86 CHEK2 (0.47) CHEK2SMAD3MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8283354-B2 Voltage gated sodium and calcium channel inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-10-09 US disclosed
US-7928107-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-04-19 US disclosed